• Je něco špatně v tomto záznamu ?

Mutation Maker, An Open Source Oligo Design Platform for Protein Engineering

K. Hiraga, P. Mejzlik, M. Marcisin, N. Vostrosablin, A. Gromek, J. Arnold, S. Wiewiora, R. Svarba, D. Prihoda, K. Clarova, O. Klempir, J. Navratil, O. Tupa, A. Vazquez-Otero, MW. Walas, L. Holy, M. Spale, J. Kotowski, D. Dzamba, G. Temesi, JH....

. 2021 ; 10 (2) : 357-370. [pub] 20210112

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004609

Protein engineering is the discipline of developing useful proteins for applications in research, therapeutic, and industrial processes by modification of naturally occurring proteins or by invention of de novo proteins. Modern protein engineering relies on the ability to rapidly generate and screen diverse libraries of mutant proteins. However, design of mutant libraries is typically hampered by scale and complexity, necessitating development of advanced automation and optimization tools that can improve efficiency and accuracy. At present, automated library design tools are functionally limited or not freely available. To address these issues, we developed Mutation Maker, an open source mutagenic oligo design software for large-scale protein engineering experiments. Mutation Maker is not only specifically tailored to multisite random and directed mutagenesis protocols, but also pioneers bespoke mutagenic oligo design for de novo gene synthesis workflows. Enabled by a novel bundle of orchestrated heuristics, optimization, constraint-satisfaction and backtracking algorithms, Mutation Maker offers a versatile toolbox for gene diversification design at industrial scale. Supported by in silico simulations and compelling experimental validation data, Mutation Maker oligos produce diverse gene libraries at high success rates irrespective of genes or vectors used. Finally, Mutation Maker was created as an extensible platform on the notion that directed evolution techniques will continue to evolve and revolutionize current and future-oriented applications.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004609
003      
CZ-PrNML
005      
20220127145121.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acssynbio.0c00542 $2 doi
035    __
$a (PubMed)33433999
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hiraga, Kaori $u Protein Engineering, MRL, Merck & Co. Inc., Rahway, New Jersey 07065, United States
245    10
$a Mutation Maker, An Open Source Oligo Design Platform for Protein Engineering / $c K. Hiraga, P. Mejzlik, M. Marcisin, N. Vostrosablin, A. Gromek, J. Arnold, S. Wiewiora, R. Svarba, D. Prihoda, K. Clarova, O. Klempir, J. Navratil, O. Tupa, A. Vazquez-Otero, MW. Walas, L. Holy, M. Spale, J. Kotowski, D. Dzamba, G. Temesi, JH. Russell, NM. Marshall, GS. Murphy, DA. Bitton
520    9_
$a Protein engineering is the discipline of developing useful proteins for applications in research, therapeutic, and industrial processes by modification of naturally occurring proteins or by invention of de novo proteins. Modern protein engineering relies on the ability to rapidly generate and screen diverse libraries of mutant proteins. However, design of mutant libraries is typically hampered by scale and complexity, necessitating development of advanced automation and optimization tools that can improve efficiency and accuracy. At present, automated library design tools are functionally limited or not freely available. To address these issues, we developed Mutation Maker, an open source mutagenic oligo design software for large-scale protein engineering experiments. Mutation Maker is not only specifically tailored to multisite random and directed mutagenesis protocols, but also pioneers bespoke mutagenic oligo design for de novo gene synthesis workflows. Enabled by a novel bundle of orchestrated heuristics, optimization, constraint-satisfaction and backtracking algorithms, Mutation Maker offers a versatile toolbox for gene diversification design at industrial scale. Supported by in silico simulations and compelling experimental validation data, Mutation Maker oligos produce diverse gene libraries at high success rates irrespective of genes or vectors used. Finally, Mutation Maker was created as an extensible platform on the notion that directed evolution techniques will continue to evolve and revolutionize current and future-oriented applications.
650    _2
$a algoritmy $7 D000465
650    _2
$a kodon $x genetika $7 D003062
650    _2
$a počítačová simulace $7 D003198
650    _2
$a řízená evoluce molekul $x metody $7 D019020
650    _2
$a Escherichia coli $x genetika $7 D004926
650    _2
$a genová knihovna $7 D015723
650    12
$a mutageneze $7 D016296
650    _2
$a mutageneze cílená $x metody $7 D016297
650    _2
$a mutantní proteiny $7 D050505
650    12
$a mutace $7 D009154
650    _2
$a oligonukleotidy $x genetika $7 D009841
650    _2
$a proteiny $x genetika $7 D011506
650    12
$a software $7 D012984
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mejzlik, Petr $u AI & Big Data Analytics, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Marcisin, Matej $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Vostrosablin, Nikita $u AI & Big Data Analytics, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Gromek, Anna $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Arnold, Jakub $u AI & Big Data Analytics, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Wiewiora, Sebastian $u AI & Big Data Analytics, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Svarba, Rastislav $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Prihoda, David $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic $u Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, 166 28 Prague, Czech Republic
700    1_
$a Clarova, Kamila $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic $u Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, 166 28 Prague, Czech Republic
700    1_
$a Klempir, Ondrej $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Navratil, Josef $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Tupa, Ondrej $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Vazquez-Otero, Alejandro $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Walas, Marcin W $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Holy, Lukas $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Spale, Martin $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Kotowski, Jakub $u AI & Big Data Analytics, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Dzamba, David $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Temesi, Gergely $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
700    1_
$a Russell, Jay H $u Protein Engineering, MRL, Merck & Co. Inc., Rahway, New Jersey 07065, United States
700    1_
$a Marshall, Nicholas M $u Protein Engineering, MRL, Merck & Co. Inc., Rahway, New Jersey 07065, United States
700    1_
$a Murphy, Grant S $u Protein Engineering, MRL, Merck & Co. Inc., Rahway, New Jersey 07065, United States
700    1_
$a Bitton, Danny A $u R&D Informatics Solutions, MSD Czech Republic s.r.o., 150 00 Prague, Czech Republic
773    0_
$w MED00186200 $t ACS synthetic biology $x 2161-5063 $g Roč. 10, č. 2 (2021), s. 357-370
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33433999 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145117 $b ABA008
999    __
$a ok $b bmc $g 1751923 $s 1155758
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 10 $c 2 $d 357-370 $e 20210112 $i 2161-5063 $m ACS synthetic biology $n ACS synth. biol. $x MED00186200
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace